logo
Share on
CONTACT US: 1.800.301.5033

WHITE PAPER

Successful BYOD in Any Phase

lunexis-logo

Go Where Your Patients Are to:

  • Improve patient enrollment, retention, and compliance
  • Recruit a more diverse patient population
  • Better patient experience
  • Improve data quality
  • Lower costs
  • Shorten build timelines
ClinicalInk_BYOD_2-16-21_VF

Clinical Ink Experience:

  • 60+ BYOD studies
  • 6-week build times
  • Predominantly Phase II/III
  • Primary endpoint outcomes
 

With regulatory agencies encouraging decentralized clinical trials and patient centricity, mobile is the way forward. Smartphones are central to patients’ lives. Roll these devices into your trial for a better, patient-centric solution. A bring your own device (BYOD) strategy allows patients to engage from anywhere: at home, on the go, at the research site.

 

BYOD can be used on its own or in addition to provisioned devices, which means greater flexibility for both sponsors and participants. BYOD is suitable for any phase, and it can scale up and out—from Phase II to Phase III and from the United States to worldwide.

Download our white paper today to find out how BYOD can fit into your clinical trial.
Through case studies and original research, this white paper answers your regulatory, technical, and copyright questions. We also show how a smart BYOD strategy gives you a competitive advantage.

Clinical Ink is the BYOD leader. You get faster deployment for greater compliance, better retention, and higher-quality data when you GO BYOD at Clinical Ink.



Download Our White Paper

 

Unlock the power of mobile. Get our BYOD white paper: